Currency in USD
Earnings estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2023) | Next year (2024) |
---|
No. of analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.08 | -0.08 | -0.37 | 0 |
Low estimate | -0.08 | -0.08 | -0.37 | 0 |
High estimate | -0.08 | -0.08 | -0.37 | 0 |
Year ago EPS | -0.17 | -0.23 | -1.23 | -0.37 |
Revenue estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2023) | Next year (2024) |
---|
No. of analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 26.27M | 26.74M | 103.73M | 118.08M |
Low estimate | 26.27M | 26.74M | 103.73M | 118.08M |
High estimate | 26.27M | 26.74M | 103.73M | 118.08M |
Year ago sales | 21.27M | 20.26M | 76.7M | 103.73M |
Sales growth (year/est) | 23.50% | 32.00% | 35.20% | 13.80% |
Earnings history | 30/12/2021 | 30/03/2022 | 29/06/2022 | 29/09/2022 |
---|
Est. EPS | -0.39 | -0.3 | -0.2 | -0.21 |
Actual EPS | -0.17 | -0.23 | -0.07 | -0.14 |
Difference | 0.22 | 0.07 | 0.13 | 0.07 |
Surprise % | 56.40% | 23.30% | 65.00% | 33.30% |
EPS trend | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2023) | Next year (2024) |
---|
Current estimate | -0.08 | -0.08 | -0.37 | 0 |
7 days ago | -0.08 | -0.08 | -0.37 | 0 |
30 days ago | -0.08 | -0.08 | -0.37 | 0 |
60 days ago | -0.08 | -0.08 | -0.37 | 0 |
90 days ago | -0.23 | -0.27 | -0.78 | -0.2 |
EPS revisions | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2023) | Next year (2024) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | MEDXF | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 52.90% | N/A | N/A | N/A |
Next qtr. | 65.20% | N/A | N/A | N/A |
Current year | 69.90% | N/A | N/A | N/A |
Next year | 100.00% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |